ArticleJMIR research protocols2026

Dosing and Safety of Once-Weekly Rifapentine and Isoniazid for 12 Weeks for Tuberculosis Preventive Therapy in Children With and Without HIV: Protocol for a Phase I/II Open-Label, Exposure-Controlled, Dose-Finding, and Safety Study (Tuberculosis Trials Consortium Study 35).

Ingrid Courtney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.